CA19-9 and Amylase Levels in Pancreatic Cancer Diagnosis

Q: CA19-9 and Amylase Levels in Pancreatic Cancer Diagnosis

Hello, <br>CA 19-9： 76.2 is elevated and abnormal. <br>Amylase is 47, which is within the normal range. <br>CA 19-9 is a tumor marker associated with pancreatic cancer, but it has low specificity and sensitivity. <br>Conditions such as biliary diseases, gallstones, pancreatitis,

CA19-9 Issues

The CA 19-9 level of 76.2 and the amylase level of 47 can provide insights into pancreatic health.
CA 19-9 is a tumor marker often elevated in pancreatic cancer, with levels above 37 U/mL typically indicating a potential malignancy.
A level of 76.2 suggests a possible concern for pancreatic cancer or other pancreatic conditions.
Amylase is an enzyme that helps digest carbohydrates, and elevated levels can indicate pancreatitis or other pancreatic disorders.
A level of 47 U/L is slightly above the normal range, which is generally considered to be 30-110 U/L, but it may not be significantly elevated.
In summary

P, 40~49 year old female. Ask Date: 2022/02/25

Dr. Lin Minghui reply Gastroenterology and Hepatology

Hello,
CA 19-9: 76.2 is elevated and abnormal.
Amylase is 47, which is within the normal range.
CA 19-9 is a tumor marker associated with pancreatic cancer, but it has low specificity and sensitivity.
Conditions such as biliary diseases, gallstones, pancreatitis, gastrointestinal diseases, cirrhosis, and cholestasis can also cause elevated CA 19-9 levels.
It is important to evaluate these results in conjunction with clinical symptoms and to follow up in an outpatient setting.
Wishing you peace and health.
Sincerely,
Dr.
Ming-Hui Lin, Attending Physician, Gastroenterology Department, Taoyuan Hospital, Ministry of Health and Welfare.

Reply Date: 2022/02/25

More Info

When interpreting the relationship between CA19-9 and Amylase levels in the context of pancreatic cancer diagnosis, it's essential to understand what each marker signifies and their limitations.

CA19-9 is a tumor marker primarily associated with pancreatic cancer, but it is not exclusively specific to this condition. Elevated levels of CA19-9 can be seen in various other conditions, including cholangitis, pancreatitis, liver cirrhosis, and even benign conditions like gallstones. In your case, a CA19-9 level of 76.2 is considered elevated, as normal levels are typically below 37 U/mL. This elevation warrants further investigation, particularly in the context of any clinical symptoms or risk factors for pancreatic cancer.

On the other hand, Amylase is an enzyme produced by the pancreas and salivary glands, and it is commonly used to diagnose conditions related to the pancreas, particularly acute pancreatitis. A normal Amylase level generally ranges from 30 to 110 U/L, depending on the laboratory. In your case, an Amylase level of 47 falls within the normal range, which suggests that there is no acute pancreatic inflammation at this time.

The relationship between these two markers can be complex. While a high CA19-9 level may raise suspicion for pancreatic cancer, a normal Amylase level can indicate that there is no active pancreatic inflammation or acute pancreatitis. This scenario could suggest that while there may be a concern for pancreatic cancer due to the elevated CA19-9, the absence of elevated Amylase levels may indicate that the pancreas is not currently inflamed or damaged.

It is crucial to interpret these results in conjunction with clinical findings and imaging studies. If there are symptoms such as unexplained weight loss, jaundice, abdominal pain, or changes in appetite, these should be taken seriously and warrant further investigation. Imaging studies such as an abdominal ultrasound, CT scan, or MRI can provide more insight into the condition of the pancreas and surrounding structures.

In summary, while an elevated CA19-9 level can be a marker for pancreatic cancer, it is not definitive on its own, especially in the absence of other symptoms or abnormal findings. The normal Amylase level is reassuring in terms of acute pancreatic conditions. It is advisable to follow up with your healthcare provider for further evaluation, which may include imaging studies and possibly a referral to a specialist in gastroenterology or oncology for a comprehensive assessment. Regular monitoring of CA19-9 levels and clinical evaluations will also be essential in managing your health and addressing any potential concerns.

Similar Q&A

Understanding Elevated CA19-9 Levels: Next Steps for Pancreatic Cancer Screening

In early February, I underwent a health check-up, which included a pancreatic cancer screening. My CA19-9 level was 51.08. What further examinations should I undergo, and what specific tests should be conducted?

Dr. Hong Hongchang reply Internal Medicine
The pancreatic cancer markers CEA and CA19-9 have been noted. Therefore, it is recommended to undergo an ultrasound examination and follow-up at a gastroenterology outpatient clinic.

Understanding CA19-9 Levels: When to Worry About Pancreatic Health

Hello doctor, three years ago my CA 19-9 level was over 5, and during a health check in February this year, it increased to over 15. After another check two months later, it rose to over 17. All other biochemical test results are normal, except for a fasting blood sugar of 101. I...

Dr. Chen Shidian reply Gastroenterology and Hepatology
CA 19-9 cannot be used to diagnose cancer. If the abdominal ultrasound is normal, it can be monitored; however, if there are still concerns, a self-paid MRI may be considered.

Understanding Elevated CA19-9 Levels: Implications for Gastrointestinal Health

Hello Doctor, I recently received my health check report, which shows a CA 19-9 value of 212 (compared to 180 the previous year). I have a chocolate cyst (for many years) and have been taking Danazol (for three months; the health check was conducted in the second month of medicat...

Dr. Lin Minghui reply Gastroenterology and Hepatology
CA 19-9 is a glycoprotein found in the human body, including in epithelial cells of the pancreas, gallbladder, and salivary glands. It is also expressed in the epithelial cells of the cervical lining. An elevated CA 19-9 level does not necessarily indicate the presence of cancer....

Understanding CA19-9 Levels: Concerns About Pancreatic Cancer Risk

Hello Doctor, I had a CA19-9 test six months ago, and the result was 28. Now it is 32. The doctor arranged for an ultrasound and said there is no fibrosis, just more fat. He advised me to reduce sugar and fried foods. The doctor scheduled a CT scan for May. I would like to ask if...

Dr. Chen Shidian reply Gastroenterology and Hepatology
The accuracy of CA19-9 is relatively low; generally, it is sufficient to monitor imaging and numerical values. Whether to perform a CT scan is a matter of personal judgment.